Swiss Life Sciences Trend Analysis 2013

Swiss Biotech financings were weaker in 2012 with only USD 117 M being raised. In the same period the number of companies increased by 9% – primarily companies in therapeutics and R&D services. Click here to download Swiss Life Sciences Trend Analysis 2013 – 12 pages Looking for your next Biotech or Medtech partner? Use … Continue reading Swiss Life Sciences Trend Analysis 2013

Read more

Swiss Life Sciences Trend Analysis 2012

With five new Biotech Therapeutic and Diagnostic companies starting up last year, Switzerland secured its place as one of the premier biotech countries in the world. Currently the leader in biotech employee’s per capita the Swiss Biotech industry outperformed in a year where the majority of countries struggled. Lead by Biocartis, the Swiss Biotech sector … Continue reading Swiss Life Sciences Trend Analysis 2012

Read more